Showing results (41-50 of 134) with videos related to
Sort By:
Pageof 14
AIDS Research and Human Retroviruses|August 2, 2011
Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label studyBernard Mole, Florence Gillaizeau, Elisabeth Carbonnel, et al.The Journal of Infectious Diseases|October 5, 2014
Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cellsMathieu F Chevalier, Céline Didier, Gaël Petitjean, et al.Frontiers in Immunology|October 18, 2016
CD4 T-Cell Responses in Primary HIV Infection: Interrelationship with Immune Activation and Virus BurdenMathieu F Chevalier, Céline Didier, Pierre-Marie Girard, et al.AIDS (London, England)|October 20, 2012
Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cARTChristophe Piketty, Béatrice Cochand-Priollet, Emilie Lanoy, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2009
Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4Eric Fontas, Isabelle Kousignian, Christian Pradier, et al.The Journal of Experimental Medicine|April 14, 2004
Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading framesSylvain Cardinaud, Arnaud Moris, Michèle Février, et al.Journal of Pediatric Gastroenterology and Nutrition|March 16, 2018
Nutritional Status in the First 2 Years of Life in Cystic Fibrosis Diagnosed by Newborn ScreeningAnne Munck, Rym Boulkedid, Laurence Weiss, et al.Journal of the American Society of Nephrology : JASN|February 24, 2004
Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 casesMarie-Agnès Dragon-Durey, Véronique Frémeaux-Bacchi, Chantal Loirat, et al.Plos One|November 20, 2014
Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control studyMatthieu Lafaurie, Barbara De Sousa, Diane Ponscarme, et al.Journal of Medical Virology|September 28, 2010
A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadirChristophe Piketty, Laurence Weiss, Lambert Assoumou, et al.Pageof 14